To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FBXO16andZNF395TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
557 supporting clones for gene FBXO16andZNF395 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DR006468 Spleen .a 1 to 565 9 to 573   tiling clone,   565/573
(98 %)
10 diff
(98.3 %id)
BG759041 B-cells, primary B-cells from tonsils (cell line) .a 36 to 660 1 to 637       637/751
(84 %)
37 diff
(95.1 %id)
BG756339 B-cells, primary B-cells from tonsils (cell line) .a 36 to 788 1 to 759       759/778
(97 %)
22 diff
(97.2 %id)
AA251839 germinal center B cell .a 94 to 424 1 to 329     Submitted on the opposite strand 329/329
(100 %)
4 diff
(98.8 %id)
CB046096 2 pooled tumors (clear cell type), Kidney .a 103 to 766 1 to 664     Submitted on the opposite strand 664/664
(100 %)
0 diff
(100 %id)
BC001237 Placenta, choriocarcinoma .a 118 to 1906 1 to 1789   tiling clone, available from MGC, AAA   1789/1789
(100 %)
0 diff
(100 %id)
AA971793 pooled .a 118 to 517 1 to 400     Submitted on the opposite strand 400/400
(100 %)
9 diff
(97.8 %id)
AW976799   .a 120 to 376 1 to 257       257/258
(99 %)
7 diff
(97.3 %id)
BE542224 cervix .a 139 to 895 1 to 764       764/897
(85 %)
33 diff
(96.4 %id)
CB046097 2 pooled tumors (clear cell type), Kidney .a 153 to 835 691 to 10     Submitted on the opposite strand 682/691
(98 %)
1 diff
(99.9 %id)
AA761154 germinal center B cell .a 163 to 326 1 to 163     Submitted on the opposite strand 163/163
(100 %)
3 diff
(98.2 %id)
AL527398 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1 to 893 1 to 893   tiling clone,   893/943
(94 %)
6 diff
(99.4 %id)
AL527357 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1916 to 2890 970 to 1   tiling clone,   970/970
(100 %)
17 diff
(98.3 %id)
DA379281 thalamus .c 1 to 562 9 to 570   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DB311324 thalamus .c 1782 to 2302 523 to 1   tiling clone,   523/523
(100 %)
2 diff
(99.7 %id)
DB180891 kidney, tumor tissue .d 1 to 500 2 to 502   tiling clone, capped   501/501
(100 %)
2 diff
(99.7 %id)
AL526770 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 54 to 948 1 to 883   tiling clone, AAA   883/924
(95 %)
16 diff
(98.3 %id)
AI076755   .d 65 to 524 1 to 460   tiling clone, Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
BG899779 cartilage .d 103 to 417 87 to 401       315/332
(94 %)
6 diff
(98.2 %id)
AL526737 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1117 to 2133 1003 to 1   tiling clone,   1003/1006
(99 %)
19 diff
(98.2 %id)
DA625382 Kidney .e 1 to 525 2 to 526   tiling clone, capped   525/525
(100 %)
0 diff
(100 %id)
DA633101 Kidney .e 7 to 539 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BQ276372 carcinoma, cell line, Prostate .e 22 to 760 18 to 757       740/1118
(66 %)
42 diff
(96.3 %id)
BX331783 Neuroblastoma Cot 25-normalized .e 24 to 1104 21 to 1089       1071/1112
(96 %)
38 diff
(96.6 %id)
BP373671 umbilical cord .e 27 to 608 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP379645 uterus .e 39 to 619 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
AK002050 placenta .e 41 to 1815 1 to 1775 exact available from FLJ,   1775/1775
(100 %)
1 diff
(100.0 %id)
AU137938 placenta .e 42 to 502 2 to 462   capped   461/461
(100 %)
1 diff
(99.8 %id)
DA464141   .e 43 to 602 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA754670   .e 43 to 570 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
CR594489 Neuroblastoma Cot 10-normalized .e 51 to 2049 1 to 1999 exact tiling clone,   1999/1999
(100 %)
0 diff
(100 %id)
AL520133 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 51 to 1045 1 to 985   fully sequenced,   985/985
(100 %)
7 diff
(99.3 %id)
AL561854 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 990 to 2034 1048 to 14   fully sequenced,   1035/1048
(98 %)
20 diff
(98.1 %id)
AU157380 placenta .e 1417 to 1815 397 to 1       397/531
(74 %)
7 diff
(98.7 %id)
AF263928   .f 1 to 2068 1 to 2068 exact tiling clone,   2068/2068
(100 %)
2 diff
(100.0 %id)
AK098243 uterus .g 1 to 2982 2 to 2983 exact tiling clone, available from FLJ,   2983/2983
(100 %)
3 diff
(99.9 %id)
DB252253 uterus .g 1 to 589 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
BE670077 carcinoid, lung .g 427 to 903 1 to 477     Submitted on the opposite strand 477/488
(97 %)
2 diff
(99.6 %id)
BE670186 carcinoid, lung .g 427 to 931 1 to 505   tiling clone, Submitted on the opposite strand 505/505
(100 %)
3 diff
(99.5 %id)
CR981019 T-Lymphocytes .g 961 to 1619 1 to 659       659/659
(100 %)
0 diff
(100 %id)
AL527319 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 985 to 1906 11 to 935       932/1073
(86 %)
22 diff
(98.0 %id)
BG684670 B-cells, primary B-cells from tonsils (cell line) .g 989 to 1560 20 to 596       578/599
(96 %)
14 diff
(97.7 %id)
TI_154188331   .g 1016 to 1824 120 to 923       804/914
(87 %)
31 diff
(96.7 %id)
BE278930 choriocarcinoma, placenta .g 1021 to 1588 1 to 571       571/571
(100 %)
5 diff
(99.2 %id)
AB044750 testis .g 1060 to 2740 1 to 1681       1681/1681
(100 %)
1 diff
(100.0 %id)
BE893950 melanotic melanoma, skin .g 1088 to 1767 670 to 1     Submitted on the opposite strand 670/807
(83 %)
14 diff
(98.3 %id)
BG419296 Kidney, renal cell adenocarcinoma .g 1147 to 1696 1 to 549       549/654
(83 %)
6 diff
(99.1 %id)
CN427916 embryonic stem cells, cell lines H1, H7, andH9 .g 1166 to 1802 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BE392204 endometrium, adenocarcinoma cell line, uterus .g 1177 to 1824 1 to 654       654/656
(99 %)
32 diff
(95.2 %id)
BE255923 eye, retinoblastoma .g 1198 to 1618 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BU429487 lymph .g 1211 to 1414 8 to 211       204/211
(96 %)
7 diff
(96.7 %id)
TI_154150564   .g 1211 to 1434 81 to 304       224/224
(100 %)
1 diff
(99.6 %id)
CR984858 T-Lymphocytes .g 1228 to 1893 1 to 667       667/670
(99 %)
3 diff
(99.6 %id)
CD629417   .g 1244 to 1827 1 to 589       589/589
(100 %)
18 diff
(97.0 %id)
BF798693 colon_ins .g 1247 to 1683 112 to 550       441/550
(80 %)
13 diff
(97.7 %id)
AA912518 pooled .g 1262 to 1474 212 to 1       212/212
(100 %)
4 diff
(98.2 %id)
BG170704 hypernephroma, cell line, Kidney .g 1338 to 1696 1 to 359       359/998
(35 %)
3 diff
(99.7 %id)
BU162658 melanotic melanoma, cell line, skin .g 1389 to 2224 1 to 843       843/895
(94 %)
25 diff
(97.3 %id)
AA355746   .g 1397 to 1697 1 to 299       299/301
(99 %)
8 diff
(97.4 %id)
DB006882 cervix, tumor tissue .g 1441 to 2007 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BI091388 cervix .g 1468 to 1715 1 to 249       249/428
(58 %)
7 diff
(98.4 %id)
CD629414   .g 1489 to 1921 1 to 432       432/432
(100 %)
5 diff
(98.9 %id)
CD629415   .g 1489 to 2026 538 to 1       538/538
(100 %)
7 diff
(98.7 %id)
BM009332 amelanotic melanoma, cell line, skin .g 1494 to 1690 1 to 198       198/351
(56 %)
4 diff
(98.9 %id)
BU520957 leiomyosarcoma, uterus .g 1495 to 2132 24 to 670       647/930
(69 %)
24 diff
(97.5 %id)
BU520958 leiomyosarcoma, uterus .g 1495 to 2101 23 to 637       615/797
(77 %)
24 diff
(97.0 %id)
AA489287   .g 1498 to 1984 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
AA065276   .g 1504 to 1908 1 to 405       405/405
(100 %)
5 diff
(98.8 %id)
BG767086 melanotic melanoma, high MDR (cell line), skin .g 1527 to 1672 1 to 146       146/146
(100 %)
0 diff
(100 %id)
BU599197 mixed (pool of 40 RNAs) .g 1545 to 2285 1 to 746       746/863
(86 %)
22 diff
(97.5 %id)
CA395811 eye, RPE/choroid .g 1568 to 2142 1 to 575       575/575
(100 %)
0 diff
(100 %id)
CN485142 eye .g 1593 to 2237 1 to 645       645/645
(100 %)
0 diff
(100 %id)
CD629416   .g 1610 to 2002 520 to 126       395/401
(98 %)
2 diff
(99.6 %id)
BG327404 Kidney, renal cell adenocarcinoma .g 1627 to 1900 1 to 270       270/270
(100 %)
8 diff
(97.1 %id)
H69909 nose, olfactory epithelium .g 1701 to 2013 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BG012711 placenta_normal .g 1730 to 2067 1 to 338       338/368
(91 %)
3 diff
(99.2 %id)
AA314958 colon .g 1739 to 1995 1 to 257       257/257
(100 %)
0 diff
(100 %id)
CN427915 embryonic stem cells, cell lines H1, H7, andH9 .g 1804 to 2261 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
R08239 liver and spleen .g 1807 to 2027 1 to 220       220/220
(100 %)
1 diff
(99.6 %id)
BU857657 adenocarcinoma, cell line, breast .g 1807 to 2668 1 to 869       869/914
(95 %)
26 diff
(97.2 %id)
BM911219 astrocytoma grade IV, cell line, brain .g 1838 to 2131 1 to 293       293/1425
(20 %)
3 diff
(99.8 %id)
AA065275   .g 1840 to 2238 8 to 404     Submitted on the opposite strand 397/405
(98 %)
15 diff
(96.3 %id)
BE531120 adenocarcinoma, Pancreas .g 1864 to 2606 1 to 742       742/742
(100 %)
6 diff
(99.2 %id)
BE615650 adenocarcinoma, Pancreas .g 1864 to 2492 1 to 638       638/905
(70 %)
25 diff
(97.3 %id)
BE615116 adenocarcinoma, Pancreas .g 1864 to 2582 1 to 716       716/720
(99 %)
4 diff
(99.5 %id)
BG991866 head_neck .g 1878 to 2439 1 to 580       558/580
(96 %)
61 diff
(89.5 %id)
AW499564 lymph .g 1898 to 2261 8 to 371       364/371
(98 %)
6 diff
(98.4 %id)
AW499567 lymph .g 1898 to 2409 8 to 519       512/519
(98 %)
6 diff
(98.9 %id)
AW502741 lymph .g 1898 to 2139 8 to 249       242/249
(97 %)
6 diff
(97.6 %id)
AW502811 lymph .g 1898 to 2188 8 to 298       291/298
(97 %)
6 diff
(98.0 %id)
CF142711 lymph .g 1898 to 2344 8 to 454       447/454
(98 %)
7 diff
(98.5 %id)
CF143178 lymph .g 1898 to 2336 8 to 446       439/450
(97 %)
8 diff
(98.3 %id)
CF143465 lymph .g 1898 to 2428 8 to 539       532/542
(98 %)
8 diff
(98.6 %id)
CF143614 lymph .g 1898 to 2426 8 to 536       529/536
(98 %)
6 diff
(98.9 %id)
CF135444 lymph .g 1898 to 2443 8 to 554       547/555
(98 %)
11 diff
(98.1 %id)
TI_154158381   .g 1898 to 2432 80 to 615       536/616
(87 %)
28 diff
(95.5 %id)
TI_154158427   .g 1898 to 2432 81 to 615       535/537
(99 %)
9 diff
(98.4 %id)
TI_154163807   .g 1898 to 2553 68 to 727       660/1415
(46 %)
13 diff
(99.1 %id)
TI_154173809   .g 1898 to 2437 78 to 618       541/640
(84 %)
6 diff
(99.1 %id)
TI_154174442   .g 1898 to 2506 89 to 700       612/615
(99 %)
14 diff
(97.8 %id)
TI_154174883   .g 1898 to 2437 80 to 621       542/739
(73 %)
3 diff
(99.6 %id)
TI_154175090   .g 1898 to 2543 80 to 729       650/659
(98 %)
20 diff
(97.0 %id)
TI_158439237   .g 1898 to 2519 85 to 705       621/623
(99 %)
19 diff
(97.0 %id)
AL562875 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 1917 to 2949 1018 to 1       1018/1070
(95 %)
31 diff
(97.2 %id)
AA095391   .g 1936 to 2130 1 to 194       194/194
(100 %)
6 diff
(97.0 %id)
BI009855 kidney_tumor .g 1953 to 2147 198 to 8       191/198
(96 %)
0 diff
(100 %id)
BF725049 eye, Iris .g 1957 to 2427 1 to 471       471/471
(100 %)
0 diff
(100 %id)
BG538142 lung .g 1961 to 2745 1 to 777       777/780
(99 %)
47 diff
(94.0 %id)
BF924312 nervous_tumor .g 1963 to 2461 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BM798110 Ascites, stomach .g 1981 to 2456 1 to 476       476/476
(100 %)
0 diff
(100 %id)
CA427069 Bone, Subchondral Bone .g 2103 to 2732 648 to 19   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 630/630
(100 %)
1 diff
(99.9 %id)
BQ086376 Islets of Langerhans, Pancreas .g 2134 to 2681 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
CK823018 Islets of Langerhans, Pancreas .g 2134 to 2728 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
BG622196 placenta .g 2189 to 2850 1 to 668       668/668
(100 %)
22 diff
(96.8 %id)
BI917232 brain .g 2266 to 2982 1 to 718   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 718/718
(100 %)
2 diff
(99.8 %id)
TI_57242296   .g 2266 to 2982 69 to 786   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 718/786
(91 %)
8 diff
(99.0 %id)
AI669340 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .g 2272 to 2739 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
BP205192 coronary artery .g 2282 to 2861 1 to 582       582/582
(100 %)
15 diff
(97.5 %id)
AW305369 brain, three pooled meningiomas .g 2302 to 2732 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AA599057 lung, lung carcinoma .g 2320 to 2733 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
BG249131 hypernephroma, cell line, Kidney .g 2329 to 2982 1 to 654   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BF059031 fibrotheoma, ovary .g 2343 to 2737 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
AI268297 carcinoid, lung .g 2345 to 2731 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
AA828531 germinal center B cell .g 2349 to 2732 392 to 11   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 382/382
(100 %)
2 diff
(99.5 %id)
AI749941 colon .g 2365 to 2735 372 to 1       372/372
(100 %)
4 diff
(99.0 %id)
AA723814 pooled .g 2372 to 2731 359 to 1       359/359
(100 %)
2 diff
(99.5 %id)
DB351173 uterus .g 2442 to 2982 541 to 1       541/541
(100 %)
1 diff
(99.9 %id)
BG391470 embryonal carcinoma, cell line, testis .g 2450 to 2778 25 to 354       330/355
(92 %)
13 diff
(96.4 %id)
BI493622 cochlea, ear .g 2465 to 2832 8 to 375       368/375
(98 %)
7 diff
(98.2 %id)
AA486431   .g 2474 to 2982 507 to 1   tiling clone,   507/507
(100 %)
2 diff
(99.7 %id)
FN088790 breast carcinoma .g 2581 to 2691 108 to 1     Submitted on the opposite strand 108/108
(100 %)
5 diff
(95.4 %id)
AA065277   .g 2582 to 2982 403 to 1     Submitted on the opposite strand 403/405
(99 %)
2 diff
(99.6 %id)
H69910 nose, olfactory epithelium .g 2593 to 2980 394 to 3       392/394
(99 %)
0 diff
(100 %id)
AB057659   .h 1 to 332 2 to 333       333/333
(100 %)
0 diff
(100 %id)
AB073627   .h 1 to 1855 2 to 1856 G140R tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1856/1856
(100 %)
1 diff
(100.0 %id)
DB029280 testis .h 1 to 579 3 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
AK023418 placenta .h 6 to 2105 1 to 2100 L464Q available from FLJ,   2100/2100
(100 %)
2 diff
(100.0 %id)
NM_018660.2   .h 6 to 4812 1 to 4807 exact RefSeq,   4807/4807
(100 %)
5 diff
(99.9 %id)
AU134574 placenta .h 7 to 605 2 to 600   capped   599/646
(92 %)
6 diff
(99.1 %id)
AU279892   .h 42 to 506 5 to 469       465/469
(99 %)
0 diff
(100 %id)
BM702140 eye, optic nerve .h 901 to 1481 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BX375207 Neuroblastoma Cot 25-normalized .h 1087 to 2102 1 to 1008   AAA Possibly primed on the genome, locally A rich (27/28 A in genome downstream of last aligned base) 1008/1010
(99 %)
20 diff
(98.1 %id)
BX099035 melanocyte .h 1239 to 1963 1 to 725       725/726
(99 %)
2 diff
(99.8 %id)
N34210 melanocyte .h 1239 to 1592 1 to 354   fully sequenced,   354/354
(100 %)
7 diff
(98.1 %id)
BG759384 B-cells, primary B-cells from tonsils (cell line) .h 1281 to 2006 1 to 725       725/725
(100 %)
2 diff
(99.8 %id)
AB044752 testis .h 1472 to 2105 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BQ448285 Knee, Osteoarthritic Cartilage .h 1476 to 2123 648 to 1       648/648
(100 %)
0 diff
(100 %id)
N25612 melanocyte .h 1531 to 2106 584 to 1   fully sequenced,   584/584
(100 %)
11 diff
(98.2 %id)
BQ102443 Islets of Langerhans, Pancreas .h 1545 to 2120 577 to 1       577/577
(100 %)
3 diff
(99.5 %id)
CK823017 Islets of Langerhans, Pancreas .h 1546 to 2120 575 to 1       575/576
(99 %)
1 diff
(99.9 %id)
DB371822 ovary, tumor tissue .h 1562 to 2105 543 to 1       543/592
(91 %)
21 diff
(96.5 %id)
AW512989 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 1580 to 2105 526 to 1       526/528
(99 %)
2 diff
(99.7 %id)
BF057402 fibrotheoma, ovary .h 1580 to 2105 526 to 1       526/528
(99 %)
18 diff
(96.6 %id)
AI553834 anaplastic oligodendroglioma, brain .h 1581 to 2107 527 to 1       527/527
(100 %)
0 diff
(100 %id)
BM930061 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1587 to 2105 1 to 519   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 519/519
(100 %)
3 diff
(99.5 %id)
AA453727 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1590 to 2111 1 to 521   fully sequenced,   521/521
(100 %)
5 diff
(99.1 %id)
BM664838 eye, optic nerve .h 1591 to 2123 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
TI_154151419   .h 1596 to 2130 619 to 81     Submitted on the opposite strand 539/540
(99 %)
32 diff
(94.1 %id)
EL949751 eyeball .h 1607 to 2105 22 to 520   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 499/520
(95 %)
6 diff
(98.9 %id)
BU743253 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1623 to 2123 501 to 1   fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 501/501
(100 %)
1 diff
(99.9 %id)
AI828000 pooled .h 1658 to 2108 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
CN427913 embryonic stem cells, DMSO-treated H9 cellline .h 1667 to 2109 443 to 1     Submitted on the opposite strand 443/443
(100 %)
0 diff
(100 %id)
BF855944 prostate_normal .h 1668 to 2040 382 to 9     Submitted on the opposite strand 374/392
(95 %)
0 diff
(100 %id)
AI094445 pooled .h 1668 to 2025 1 to 356     Submitted on the opposite strand 356/356
(100 %)
2 diff
(99.5 %id)
AI285881 pooled .h 1683 to 2108 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AU155510 placenta .h 1697 to 2105 411 to 1       411/454
(90 %)
4 diff
(99.2 %id)
AW069582 bone marrow stroma .h 1699 to 2127 429 to 1       429/429
(100 %)
0 diff
(100 %id)
BQ216334 large cell carcinoma, lung .h 1710 to 2595 1 to 889   tiling clone,   889/890
(99 %)
8 diff
(99.2 %id)
BG030446 breast, mammary adenocarcinoma, cell line .h 1711 to 2126 1 to 418       418/1253
(33 %)
10 diff
(99.3 %id)
AA834940   .h 1712 to 2110 399 to 1       399/403
(99 %)
0 diff
(100 %id)
F20465 pectoral muscle (after mastectomy) .h 1721 to 2106 1 to 386       386/386
(100 %)
0 diff
(100 %id)
AA972138 pooled .h 1729 to 2112 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AW305193 brain, three pooled meningiomas .h 1731 to 2106 376 to 1       376/376
(100 %)
0 diff
(100 %id)
AA251814 germinal center B cell .h 1763 to 2121 359 to 1     Submitted on the opposite strand 359/359
(100 %)
0 diff
(100 %id)
BU430150 lymph .h 1766 to 2136 372 to 2     Submitted on the opposite strand 371/372
(99 %)
0 diff
(100 %id)
AA598932   .h 1770 to 2111 342 to 1       342/342
(100 %)
1 diff
(99.8 %id)
AA625946 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1793 to 2108 316 to 1       316/316
(100 %)
0 diff
(100 %id)
Z39516 brain, total brain .h 1797 to 2105 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AA701339 liver and spleen .h 1804 to 2107 304 to 1       304/304
(100 %)
0 diff
(100 %id)
TI_57164465   .h 1807 to 2105 82 to 379   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 298/379
(78 %)
6 diff
(98.5 %id)
BI834135 pooled pancreas and spleen .h 1808 to 2133 1 to 328       328/334
(98 %)
7 diff
(98.0 %id)
AW270206 normal squamous epithelium, tongue .h 1811 to 2104 294 to 1       294/301
(97 %)
0 diff
(100 %id)
M79208   .h 1822 to 2105 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AI470500 pooled .h 1823 to 2106 287 to 1       287/287
(100 %)
4 diff
(98.7 %id)
BM727178 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1845 to 2105 16 to 276   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 261/276
(94 %)
6 diff
(97.9 %id)
AI185371 lung .h 1850 to 2112 264 to 1       264/264
(100 %)
1 diff
(99.7 %id)
AW275618 normal squamous epithelium, tongue .h 1851 to 2104 252 to 1       252/252
(100 %)
3 diff
(98.9 %id)
AA625924   .h 1868 to 2108 241 to 1       241/241
(100 %)
1 diff
(99.6 %id)
BQ425829 melanotic melanoma, skin .h 1868 to 2671 26 to 831       806/835
(96 %)
26 diff
(96.9 %id)
BQ432067 melanotic melanoma, skin .h 1868 to 2628 24 to 793       770/908
(84 %)
18 diff
(98.1 %id)
DA472703   .h 1874 to 2355 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
AI721111 colon .h 1882 to 2111 232 to 3       230/232
(99 %)
0 diff
(100 %id)
BX348685 Neuroblastoma Cot 25-normalized .h 1885 to 2114 1 to 230       230/230
(100 %)
8 diff
(96.6 %id)
BM681647 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1886 to 2123 237 to 1   fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 237/237
(100 %)
1 diff
(99.6 %id)
AW023841 cochlea, ear .h 1887 to 2105 1 to 219   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 219/219
(100 %)
4 diff
(98.2 %id)
AW015831   .h 1894 to 2122 229 to 1       229/235
(97 %)
1 diff
(99.6 %id)
BU565709 mixed (pool of 40 RNAs) .h 1897 to 2109 1 to 213       213/214
(99 %)
1 diff
(99.6 %id)
CV573604 cornea, eye .h 1925 to 2513 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
AA447796 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1927 to 2114 188 to 1   fully sequenced,   188/188
(100 %)
0 diff
(100 %id)
DA289474 hippocampus .h 1942 to 2498 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
AU127908   .h 1944 to 2453 2 to 510   capped   509/516
(98 %)
9 diff
(98.3 %id)
CX784968 human embryonic stem cells .h 1950 to 2129 181 to 2     Submitted on the opposite strand 180/181
(99 %)
0 diff
(100 %id)
AW518371 lymph node, lymphoma, follicular mixed small and largecell .h 1953 to 2105 153 to 1       153/153
(100 %)
0 diff
(100 %id)
BI962651 Islets of Langerhans, Pancreas .h 1961 to 2114 1 to 154       154/154
(100 %)
0 diff
(100 %id)
CB960515 Human Placenta, placenta .h 1985 to 2522 27 to 559       533/630
(84 %)
8 diff
(98.8 %id)
CN427914 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1986 to 2330 1 to 347       347/347
(100 %)
4 diff
(98.9 %id)
BM810612 astrocytoma grade IV, cell line, brain .h 1997 to 2911 10 to 925       916/1083
(84 %)
6 diff
(99.5 %id)
BE241876 leukopheresis .h 2086 to 2450 1 to 363       363/363
(100 %)
5 diff
(98.7 %id)
BM149037 leukopheresis .h 2086 to 2669 1 to 584       584/584
(100 %)
10 diff
(98.3 %id)
BM838006 Ascites, stomach .h 2109 to 2640 1 to 533       533/533
(100 %)
3 diff
(99.5 %id)
AK026076   .h 2139 to 4615 1 to 2471   available from FLJ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2471/2471
(100 %)
5 diff
(99.8 %id)
BG996619 head_neck .h 2139 to 2565 14 to 437       424/437
(97 %)
6 diff
(98.7 %id)
AA342845 Spleen .h 2165 to 2459 295 to 1       295/296
(99 %)
0 diff
(100 %id)
N44101 melanocyte .h 2190 to 2536 1 to 353       353/465
(75 %)
12 diff
(97.5 %id)
AA347918 heart .h 2197 to 2471 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AW961767   .h 2198 to 2643 1 to 444       444/458
(96 %)
12 diff
(97.4 %id)
BF856921 prostate_tumor .h 2296 to 2405 111 to 1     Submitted on the opposite strand 111/111
(100 %)
4 diff
(96.4 %id)
CA389478 eye, RPE/choroid .h 2310 to 2805 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
CA773975 Pancreas, Purified pancreatic islet .h 2312 to 2909 1 to 598   fully sequenced,   598/598
(100 %)
2 diff
(99.7 %id)
DA960034 Spleen .h 2313 to 2849 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
BP373269 umbilical cord .h 2320 to 2901 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA987900 synovial membrane tissue from rheumatioidarthritis .h 2321 to 2881 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB113180 thymus .h 2323 to 2839 2 to 518   capped   517/526
(98 %)
2 diff
(99.7 %id)
AW294261   .h 2333 to 2648 333 to 18   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 316/330
(95 %)
0 diff
(100 %id)
AU279750   .h 2336 to 2892 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA628120 Kidney .h 2358 to 2884 2 to 528   capped   527/528
(99 %)
1 diff
(99.9 %id)
AI340252 pooled germ cell tumors .h 2365 to 2649 289 to 5       285/289
(98 %)
0 diff
(100 %id)
AI335635 pooled germ cell tumors .h 2366 to 2648 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AW590717 pooled germ cell tumors .h 2366 to 2648 283 to 1       283/283
(100 %)
3 diff
(99.0 %id)
CN264452 embryonic stem cells, cell lines H1, H7, andH9 .h 2409 to 2813 1 to 405       405/405
(100 %)
0 diff
(100 %id)
C75086   .h 2460 to 2883 1 to 425       425/431
(98 %)
4 diff
(99.1 %id)
BM715444 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2462 to 3043 1 to 583   fully sequenced,   583/583
(100 %)
1 diff
(99.9 %id)
BC002919 Placenta, choriocarcinoma .h 2463 to 4615 10 to 2162   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2153/2153
(100 %)
2 diff
(100.0 %id)
AA490113   .h 2467 to 2866 1 to 400     Submitted on the opposite strand 400/400
(100 %)
0 diff
(100 %id)
BE900315 choriocarcinoma, placenta .h 2482 to 3183 1 to 698   available from MGC,   698/699
(99 %)
7 diff
(99.0 %id)
BM703421 eye, human retina .h 2484 to 2901 1 to 418     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
T10609   .h 2488 to 2793 1 to 312     Submitted on the opposite strand 312/312
(100 %)
7 diff
(97.8 %id)
AA171502   .h 2512 to 2746 1 to 237     Submitted on the opposite strand 237/238
(99 %)
5 diff
(97.9 %id)
AA204851   .h 2512 to 2873 1 to 375     Submitted on the opposite strand 375/430
(87 %)
16 diff
(96.3 %id)
AA121160 colon, tumor .h 2514 to 2906 1 to 394     Submitted on the opposite strand 394/394
(100 %)
1 diff
(99.8 %id)
DR004038 Liver .h 2550 to 3201 1 to 650       650/650
(100 %)
3 diff
(99.6 %id)
DA951116 Spleen .h 2577 to 3109 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BP366744 thymus .h 2580 to 3159 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA516199 brain .h 2581 to 3127 2 to 550   capped   549/549
(100 %)
4 diff
(99.3 %id)
DA593404 lung .h 2581 to 3154 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA667759 esophagus .h 2581 to 3143 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA376666 thalamus .h 2582 to 3131 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA622104 Kidney .h 2582 to 3127 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA643294   .h 2582 to 3119 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DB183849 liver, tumor tissue .h 2583 to 3152 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA600763   .h 2595 to 3161 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CB270814 adipose .h 2606 to 3181 1 to 578       578/586
(98 %)
6 diff
(99.0 %id)
AK312078 Spleen .h 2616 to 3269 1 to 654       654/654
(100 %)
0 diff
(100 %id)
DA931143 Spleen .h 2617 to 3381 2 to 763   capped   762/762
(100 %)
4 diff
(99.5 %id)
BP333805 salivary gland .h 2625 to 3205 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
DB119346 thymus .h 2625 to 3198 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BE669771 carcinoid, lung .h 2627 to 2958 1 to 332     Submitted on the opposite strand 332/332
(100 %)
0 diff
(100 %id)
CN365090 embryonic stem cells, DMSO-treated H9 cellline .h 2647 to 3167 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
DB473854 hippocampus .h 2659 to 3139 1 to 481       481/481
(100 %)
3 diff
(99.4 %id)
BG988249 head_neck .h 2677 to 3144 1 to 469       469/469
(100 %)
14 diff
(97.1 %id)
BQ355098 head_neck .h 2677 to 3191 1 to 516       516/516
(100 %)
18 diff
(96.6 %id)
AW606651 head_neck .h 2678 to 3153 518 to 41       478/518
(92 %)
0 diff
(100 %id)
BG988243 head_neck .h 2678 to 3146 11 to 479       469/479
(97 %)
6 diff
(98.8 %id)
BG988255 head_neck .h 2681 to 3154 9 to 479       471/479
(98 %)
6 diff
(98.8 %id)
BI002179 head_normal .h 2688 to 2842 9 to 164       156/164
(95 %)
6 diff
(96.4 %id)
AL137588 testis .h 2690 to 4801 1 to 2118   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2118/2118
(100 %)
3 diff
(99.9 %id)
BG987014 head_neck .h 2691 to 3046 387 to 31       357/387
(92 %)
0 diff
(100 %id)
BG987006 head_neck .h 2692 to 3201 38 to 545       508/554
(91 %)
4 diff
(99.3 %id)
AL039399 testis .h 2695 to 3057 1 to 364     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 364/366
(99 %)
5 diff
(98.7 %id)
CA391823 eye, RPE/choroid .h 2699 to 3069 1 to 371       371/371
(100 %)
0 diff
(100 %id)
CA394921 eye, RPE/choroid .h 2708 to 3195 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BI005099 head_normal .h 2711 to 3343 639 to 10       630/639
(98 %)
0 diff
(100 %id)
DA647231 mammary gland .h 2711 to 3361 2 to 650   capped   649/649
(100 %)
2 diff
(99.7 %id)
DA963063 stomach .h 2719 to 3296 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BF308572 muscle, rhabdomyosarcoma .h 2739 to 3388 1 to 652   available from MGC,   652/865
(75 %)
16 diff
(98.2 %id)
BC008870 Muscle, rhabdomyosarcoma .h 2740 to 4615 1 to 1876   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1876/1876
(100 %)
2 diff
(99.9 %id)
FN091554 breast carcinoma .h 2779 to 2871 1 to 96       96/98
(97 %)
7 diff
(92.9 %id)
BU428919 lymph .h 2781 to 2920 1 to 140       140/140
(100 %)
4 diff
(97.2 %id)
BG988247 head_neck .h 2787 to 3349 573 to 12       562/573
(98 %)
0 diff
(100 %id)
AW815421 stomach .h 2808 to 3186 391 to 13       379/391
(96 %)
0 diff
(100 %id)
BE925376 amnion_normal .h 2813 to 2971 33 to 192       160/192
(83 %)
6 diff
(96.9 %id)
BG014393 placenta_normal .h 2814 to 3092 545 to 267       279/545
(51 %)
0 diff
(100 %id)
CN365091 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 2830 to 3413 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BC063660 Placenta, choriocarcinoma .h 2835 to 4615 1 to 1781   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1781/1781
(100 %)
2 diff
(99.9 %id)
BI092928 cervix .h 2836 to 3447 1 to 609   available from MGC,   609/784
(77 %)
11 diff
(98.6 %id)
BE383532 brain, neuroblastoma .h 2858 to 3415 1 to 590       590/649
(90 %)
32 diff
(95.1 %id)
BQ030068 lung, Metastatic Chondrosarcoma .h 2872 to 3435 582 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 564/564
(100 %)
0 diff
(100 %id)
BI055691 placenta_normal .h 2880 to 3342 480 to 11       470/492
(95 %)
0 diff
(100 %id)
BF336840 colon .h 2881 to 3280 411 to 13       399/425
(93 %)
0 diff
(100 %id)
BI754634 brain .h 2885 to 3743 1 to 866       866/867
(99 %)
42 diff
(95.2 %id)
TI_57217266   .h 2885 to 3743 35 to 900       866/901
(96 %)
42 diff
(95.4 %id)
BG986997 head_neck .h 2889 to 3412 548 to 27       522/548
(95 %)
0 diff
(100 %id)
AA339884 epithelium, skin .h 2898 to 3202 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
BG987012 head_neck .h 2899 to 3405 527 to 20       508/527
(96 %)
0 diff
(100 %id)
BI001404 head_normal .h 2899 to 3345 470 to 24       447/470
(95 %)
0 diff
(100 %id)
BQ027024 Chondrosarcoma, Left Pubic Bone .h 2900 to 3435 556 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 538/538
(100 %)
4 diff
(99.3 %id)
BU069252 Pancreas, Purified pancreatic islet .h 2902 to 3434 535 to 1   fully sequenced,   535/535
(100 %)
1 diff
(99.9 %id)
BM722831 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2905 to 3435 1 to 531   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 531/531
(100 %)
0 diff
(100 %id)
BQ029399 lung, Metastatic Chondrosarcoma .h 2915 to 3435 539 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 521/521
(100 %)
0 diff
(100 %id)
BP398831 pancreatic islet .h 2923 to 3407 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
N36098 melanocyte .h 2927 to 3435 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
BU075708 insulinoma, Pancreas .h 2960 to 3414 455 to 1       455/455
(100 %)
6 diff
(98.7 %id)
BU729352 eye, human retina .h 2961 to 3435 493 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 475/475
(100 %)
0 diff
(100 %id)
AI432423 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 2980 to 3434 455 to 1       455/457
(99 %)
2 diff
(99.6 %id)
AI333169 lung .h 2986 to 3435 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI498836 anaplastic oligodendroglioma, brain .h 2986 to 3435 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI192746 lung .h 2997 to 3434 439 to 1       439/439
(100 %)
1 diff
(99.8 %id)
AA847888 germinal center B cell .h 3006 to 3439 434 to 1       434/434
(100 %)
2 diff
(99.6 %id)
BM673926 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 3013 to 3453 441 to 1   fully sequenced,   441/441
(100 %)
4 diff
(99.1 %id)
AA574248 breast .h 3039 to 3434 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AA897467 pooled .h 3040 to 3434 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
BG324220 Kidney, renal cell adenocarcinoma .h 3046 to 3417 2 to 373       372/983
(37 %)
11 diff
(98.9 %id)
AW962476   .h 3084 to 3413 333 to 1     Submitted on the opposite strand 333/333
(100 %)
21 diff
(93.7 %id)
AI221449 pooled .h 3084 to 3434 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AI240631 pooled .h 3084 to 3434 353 to 1       353/353
(100 %)
2 diff
(99.5 %id)
BF761772 colon_est .h 3092 to 3410 326 to 8     Submitted on the opposite strand 319/326
(97 %)
0 diff
(100 %id)
BP396603 pancreatic islet .h 3114 to 3386 1 to 273     Submitted on the opposite strand 273/278
(98 %)
1 diff
(99.7 %id)
BM051326 eye, normal pigmented retinal epithelium .h 3130 to 3713 1 to 585       585/762
(76 %)
36 diff
(95.3 %id)
BI002150 head_normal .h 3183 to 3343 176 to 10       167/178
(93 %)
0 diff
(100 %id)
BQ050202 leiomyosarcoma, uterus .h 3190 to 3939 1 to 761       761/1140
(66 %)
24 diff
(97.9 %id)
AA603411   .h 3210 to 3429 238 to 21       218/238
(91 %)
0 diff
(100 %id)
BF339648 brain, glioblastoma with EGFR amplification .h 3222 to 3938 1 to 715       715/948
(75 %)
26 diff
(97.3 %id)
BE746388 adenocarcinoma cell line, ovary .h 3251 to 4025 12 to 802       791/802
(98 %)
6 diff
(99.3 %id)
BP394797 pancreatic islet .h 3299 to 3797 499 to 1       499/499
(100 %)
1 diff
(99.8 %id)
AA441953   .h 3305 to 3613 1 to 309       309/309
(100 %)
0 diff
(100 %id)
CB268814 adipose .h 3309 to 3448 1 to 140       140/140
(100 %)
0 diff
(100 %id)
CN365089 embryonic stem cells, DMSO-treated H9 cellline .h 3313 to 3968 9 to 664       656/664
(98 %)
6 diff
(99.1 %id)
BM712446 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 3336 to 3794 1 to 458     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 458/458
(100 %)
2 diff
(99.6 %id)
AI027852 B-cell, chronic lymphotic leukemia .h 3345 to 3436 92 to 1       92/98
(93 %)
1 diff
(99.0 %id)
CD236899 Pituitary .h 3360 to 4057 1 to 697       697/698
(99 %)
5 diff
(99.3 %id)
CA445812 Chondrosarcoma, Left Pelvis .h 3410 to 3867 1 to 456     Submitted on the opposite strand 456/456
(100 %)
3 diff
(99.4 %id)
BG755077 B-cells, primary B-cells from tonsils (cell line) .h 3411 to 4081 671 to 2     Submitted on the opposite strand 670/1151
(58 %)
0 diff
(100 %id)
AW298622   .h 3414 to 3868 1 to 455     Submitted on the opposite strand 455/455
(100 %)
3 diff
(99.4 %id)
R45910   .h 3416 to 3542 1 to 141       141/141
(100 %)
6 diff
(95.8 %id)
BF743361 breast .h 3426 to 3731 309 to 4     Submitted on the opposite strand 306/309
(99 %)
0 diff
(100 %id)
AA563808 normal prostate, Prostate .h 3426 to 3874 1 to 450     Submitted on the opposite strand 450/450
(100 %)
1 diff
(99.8 %id)
AA939209 pooled .h 3426 to 3864 1 to 439     Submitted on the opposite strand 439/439
(100 %)
1 diff
(99.8 %id)
AI814553 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .h 3427 to 3853 1 to 427     Submitted on the opposite strand 427/427
(100 %)
4 diff
(99.1 %id)
CF455402 peripheral nervous system .h 3452 to 4255 29 to 828       800/831
(96 %)
13 diff
(98.5 %id)
CF455382 peripheral nervous system .h 3452 to 4228 29 to 803       775/809
(95 %)
9 diff
(98.9 %id)
BU580991 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .h 3466 to 3943 13 to 490       478/490
(97 %)
6 diff
(98.8 %id)
BF086375 placenta_normal .h 3505 to 3750 1 to 246       246/246
(100 %)
10 diff
(96.0 %id)
CA395239 eye, RPE/choroid .h 3533 to 4150 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BQ948829 eye, normal pigmented retinal epithelium .h 3542 to 4481 1 to 944       944/944
(100 %)
14 diff
(98.6 %id)
AA328820   .h 3568 to 3901 1 to 333       333/333
(100 %)
4 diff
(98.8 %id)
BG759667 B-cells, primary B-cells from tonsils (cell line) .h 3568 to 4390 1 to 824       824/831
(99 %)
12 diff
(98.6 %id)
AW961429   .h 3569 to 4006 1 to 442       442/445
(99 %)
30 diff
(93.3 %id)
BU145388 epidermoid carcinoma, cell line, salivary gland .h 3573 to 4535 1 to 963       963/963
(100 %)
42 diff
(95.7 %id)
C17620 placenta .h 3574 to 3811 1 to 238       238/238
(100 %)
5 diff
(97.9 %id)
AW293990   .h 3576 to 3949 416 to 38   AAA   379/400
(94 %)
0 diff
(100 %id)
BG167313 hypernephroma, cell line, Kidney .h 3604 to 4366 1 to 758       758/975
(77 %)
22 diff
(97.8 %id)
T18550   .h 3606 to 3744 1 to 138       138/138
(100 %)
2 diff
(98.6 %id)
DB504639 hypothalamus .h 3631 to 4101 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
CU446256 epidermis .h 3634 to 4133 23 to 522       500/522
(95 %)
6 diff
(98.9 %id)
BG432892 Kidney .h 3653 to 4429 1 to 774       774/819
(94 %)
15 diff
(98.2 %id)
CN365092 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 3701 to 4227 17 to 543       527/543
(97 %)
6 diff
(98.9 %id)
R34037 placenta .h 3725 to 4089 1 to 378       378/379
(99 %)
15 diff
(96.1 %id)
BM720529 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 3735 to 4247 1 to 513     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 513/513
(100 %)
2 diff
(99.7 %id)
BE439990 Trabecular meshwork .h 3751 to 4290 1 to 538       538/538
(100 %)
4 diff
(99.3 %id)
BP318044 pericardium .h 3768 to 4349 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BG673977 skin .h 3779 to 4618 1 to 839       839/842
(99 %)
10 diff
(98.9 %id)
BU581101 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .h 3788 to 4211 11 to 434       424/434
(97 %)
6 diff
(98.7 %id)
CD628350   .h 3791 to 4059 1 to 269       269/287
(93 %)
4 diff
(98.7 %id)
BP296630   .h 3791 to 4371 1 to 584       584/584
(100 %)
6 diff
(99.0 %id)
W03673 liver and spleen .h 3793 to 4020 1 to 229       229/229
(100 %)
2 diff
(99.2 %id)
CD628349   .h 3796 to 4059 277 to 14       264/282
(93 %)
0 diff
(100 %id)
CN485334 eye .h 3797 to 4355 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
BE884344 leiomyosarcoma, uterus .h 3799 to 4539 1 to 739       739/755
(97 %)
24 diff
(96.9 %id)
TI_149287137   .h 3801 to 4783 1061 to 82   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 980/1148
(85 %)
36 diff
(96.9 %id)
AW794926 uterus .h 3810 to 4149 9 to 348       340/348
(97 %)
6 diff
(98.3 %id)
BU169203 epidermoid carcinoma, cell line, salivary gland .h 3811 to 4593 1 to 785       785/899
(87 %)
14 diff
(98.5 %id)
BX115988 normal prostate, Prostate .h 3814 to 4642 1 to 831       831/831
(100 %)
3 diff
(99.7 %id)
AA662205 normal prostate, Prostate .h 3814 to 4298 1 to 485       485/485
(100 %)
6 diff
(98.8 %id)
FN086431 breast carcinoma .h 3821 to 3938 119 to 1     Submitted on the opposite strand 119/119
(100 %)
1 diff
(99.2 %id)
BG249782 hypernephroma, cell line, Kidney .h 3833 to 4626 1 to 783       783/787
(99 %)
19 diff
(97.6 %id)
AA382847 testis .h 3863 to 4175 1 to 313       313/313
(100 %)
2 diff
(99.4 %id)
CA435076 lung, Lung Focal Fibrosis .h 3885 to 4575 4 to 694     Submitted on the opposite strand 691/694
(99 %)
7 diff
(99.0 %id)
BE729337 melanotic melanoma, skin .h 3915 to 4012 657 to 763       675/863
(78 %)
69 diff
(92.1 %id)
CA411695 Knee, Osteoarthritic Cartilage .h 3916 to 4615 717 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 699/699
(100 %)
4 diff
(99.5 %id)
TI_159715625   .h 3921 to 4803 968 to 86   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 883/1004
(87 %)
12 diff
(98.9 %id)
FN155383 breast carcinoma .h 3942 to 4043 100 to 1     Submitted on the opposite strand 100/103
(97 %)
2 diff
(98.1 %id)
AV753572 Pituitary .h 3958 to 4615 328 to 984   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 657/984
(66 %)
10 diff
(99.0 %id)
BM675972 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 3959 to 4615 676 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 658/658
(100 %)
1 diff
(99.9 %id)
CB242576 Human Lung Epithelial cells, lung .h 3960 to 4615 673 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 655/655
(100 %)
3 diff
(99.6 %id)
TI_154043151   .h 3970 to 4780 896 to 91   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 806/979
(82 %)
25 diff
(97.5 %id)
BF921799 nervous_tumor .h 3986 to 4327 1 to 340       340/340
(100 %)
6 diff
(98.3 %id)
H95738 liver and spleen .h 4002 to 4197 1 to 200       200/200
(100 %)
9 diff
(95.5 %id)
CD356465 Blood vessels - aorta, basilar and artery .h 4005 to 4565 1 to 567       567/803
(70 %)
15 diff
(98.2 %id)
TI_154168464   .h 4031 to 4807 891 to 114     Submitted on the opposite strand 778/799
(97 %)
0 diff
(100 %id)
CB852411 Human Lung Epithelial cells, lung .h 4056 to 4803 768 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 752/752
(100 %)
3 diff
(99.7 %id)
BM805117 ovary (pool of 3) .h 4059 to 4783 21 to 749       729/749
(97 %)
0 diff
(100 %id)
DB362089 mammary gland .h 4066 to 4615 548 to 1       548/548
(100 %)
7 diff
(98.8 %id)
N87322   .h 4068 to 4384 1 to 310       310/331
(93 %)
24 diff
(92.8 %id)
BM972510 lung .h 4080 to 4783 721 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 706/706
(100 %)
1 diff
(99.9 %id)
C00558   .h 4083 to 4381 1 to 298       298/298
(100 %)
1 diff
(99.7 %id)
BU580646 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .h 4085 to 4616 532 to 1       532/532
(100 %)
0 diff
(100 %id)
H83038 liver and spleen .h 4087 to 4498 1 to 419       419/422
(99 %)
18 diff
(95.8 %id)
BI094760 bone marrow .h 4095 to 4240 1 to 146     Submitted on the opposite strand 146/149
(97 %)
3 diff
(98.0 %id)
AA129404 lung, lung carcinoma .h 4102 to 4585 485 to 1       485/489
(99 %)
6 diff
(98.8 %id)
DB364980   .h 4105 to 4615 511 to 1       511/545
(93 %)
11 diff
(98.0 %id)
BP397727 pancreatic islet .h 4117 to 4615 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
BM714231 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 4120 to 4615 1 to 496   fully sequenced,   496/496
(100 %)
5 diff
(99.0 %id)
TI_151753671   .h 4120 to 4636 598 to 81       518/1284
(40 %)
17 diff
(98.7 %id)
BQ448498 Knee, Osteoarthritic Cartilage .h 4122 to 4608 514 to 26   AAA   489/496
(98 %)
0 diff
(100 %id)
AI140127 heart .h 4132 to 4606 486 to 12       475/486
(97 %)
0 diff
(100 %id)
AL039400 testis .h 4139 to 4801 699 to 28   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 672/676
(99 %)
15 diff
(97.8 %id)
N24770 melanocyte .h 4141 to 4615 475 to 1       475/475
(100 %)
0 diff
(100 %id)
TI_154150373   .h 4144 to 4628 561 to 77     Submitted on the opposite strand 485/820
(59 %)
0 diff
(100 %id)
AI885705 anaplastic oligodendroglioma, brain .h 4159 to 4615 457 to 1       457/457
(100 %)
0 diff
(100 %id)
BM998526 lung, Metastatic Chondrosarcoma .h 4161 to 4801 662 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
AI139522 uterus .h 4162 to 4613 454 to 3       452/454
(99 %)
0 diff
(100 %id)
AW118992 pooled .h 4162 to 4614 453 to 1       453/453
(100 %)
2 diff
(99.6 %id)
AA864279 Kidney, kidney tumor .h 4167 to 4615 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
AA668916 lung .h 4179 to 4614 436 to 1       436/436
(100 %)
0 diff
(100 %id)
AA171602   .h 4187 to 4616 434 to 1     Submitted on the opposite strand 434/434
(100 %)
4 diff
(99.1 %id)
AI696929 adenocarcinoma, Pancreas .h 4187 to 4616 430 to 1       430/430
(100 %)
0 diff
(100 %id)
CN480409 Knee, Osteoarthritic Cartilage .h 4191 to 4780 612 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 594/594
(100 %)
3 diff
(99.5 %id)
AI814745 adenocarcinoma, Pancreas .h 4210 to 4617 408 to 1       408/408
(100 %)
2 diff
(99.6 %id)
AI057234 liver and spleen .h 4213 to 4618 406 to 1       406/406
(100 %)
0 diff
(100 %id)
BM701325 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 4216 to 4633 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
BM717048 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 4216 to 4801 1 to 590   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 590/590
(100 %)
2 diff
(99.7 %id)
CF138517 lymph .h 4218 to 4807 618 to 29     Submitted on the opposite strand 590/618
(95 %)
0 diff
(100 %id)
AA378415 synovial membrane .h 4221 to 4563 1 to 346       346/346
(100 %)
3 diff
(99.2 %id)
AW511846 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 4227 to 4618 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
BY996959   .h 4227 to 4787 602 to 36     Submitted on the opposite strand 567/602
(94 %)
0 diff
(100 %id)
AI432792 lymph node, lymphoma, follicular mixed small and largecell .h 4232 to 4617 386 to 1       386/386
(100 %)
0 diff
(100 %id)
BU429353 lymph .h 4233 to 4628 405 to 10     Submitted on the opposite strand 396/405
(97 %)
0 diff
(100 %id)
N80146 liver and spleen .h 4240 to 4615 381 to 1       381/384
(99 %)
8 diff
(98.0 %id)
TI_154145079   .h 4241 to 4777 618 to 79     Submitted on the opposite strand 540/629
(85 %)
25 diff
(96.1 %id)
W25094 lung .h 4243 to 4516 1 to 274   fully sequenced,   274/274
(100 %)
2 diff
(99.3 %id)
AI567567 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 4246 to 4617 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
AA122378 colon, tumor .h 4250 to 4616 367 to 1     Submitted on the opposite strand 367/367
(100 %)
0 diff
(100 %id)
H27740 breast .h 4258 to 4613 366 to 8       359/366
(98 %)
0 diff
(100 %id)
BU580535 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .h 4260 to 4804 550 to 1       550/550
(100 %)
2 diff
(99.7 %id)
AA359095 lung .h 4265 to 4604 343 to 1     Submitted on the opposite strand 343/344
(99 %)
3 diff
(99.2 %id)
R63270 placenta .h 4265 to 4590 1 to 326   fully sequenced,   326/326
(100 %)
0 diff
(100 %id)
BM678808 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 4271 to 4780 538 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 520/520
(100 %)
6 diff
(98.9 %id)
AA131721 uterus .h 4279 to 4430 1 to 153   fully sequenced,   153/153
(100 %)
2 diff
(98.7 %id)
AA204900   .h 4279 to 4802 522 to 4     Submitted on the opposite strand 519/522
(99 %)
0 diff
(100 %id)
W57576 heart .h 4282 to 4616 1 to 334       334/334
(100 %)
1 diff
(99.8 %id)
BF061439 pooled .h 4300 to 4786 491 to 1       491/491
(100 %)
3 diff
(99.4 %id)
BF058945 fibrotheoma, ovary .h 4300 to 4801 507 to 1       507/507
(100 %)
3 diff
(99.5 %id)
AI871719 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 4302 to 4804 508 to 4       505/508
(99 %)
0 diff
(100 %id)
CN365093 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 4313 to 4625 313 to 1     Submitted on the opposite strand 313/313
(100 %)
0 diff
(100 %id)
DB332350 Spleen .h 4313 to 4790 490 to 12       479/492
(97 %)
0 diff
(100 %id)
AI700223 colon .h 4315 to 4617 303 to 1       303/303
(100 %)
0 diff
(100 %id)
AI457676 pooled .h 4318 to 4786 473 to 1       473/473
(100 %)
5 diff
(99.0 %id)
C75552   .h 4322 to 4787 473 to 6       468/473
(98 %)
0 diff
(100 %id)
AI432486 adenocarcinoma, Pancreas .h 4322 to 4618 297 to 1       297/297
(100 %)
0 diff
(100 %id)
DB575884 hypothalamus .h 4329 to 4802 1 to 478     Submitted on the opposite strand 478/482
(99 %)
4 diff
(99.2 %id)
AI811001 Prostate .h 4329 to 4784 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AW028941 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 4332 to 4799 463 to 1       463/551
(84 %)
10 diff
(98.2 %id)
C75461   .h 4344 to 4787 448 to 6       443/449
(98 %)
0 diff
(100 %id)
DB542634 hippocampus .h 4356 to 4799 1 to 448     Submitted on the opposite strand 448/450
(99 %)
3 diff
(99.4 %id)
BP395293 pancreatic islet .h 4357 to 4619 1 to 263     Submitted on the opposite strand 263/263
(100 %)
2 diff
(99.3 %id)
BM676611 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 4360 to 4628 274 to 1   fully sequenced,   274/274
(100 %)
5 diff
(98.2 %id)
AA602132   .h 4367 to 4766 1 to 399       399/399
(100 %)
7 diff
(98.3 %id)
AA662165 normal prostate, Prostate .h 4376 to 4801 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
BQ023861 placenta .h 4378 to 4787 428 to 15       414/428
(96 %)
0 diff
(100 %id)
AW407202 lymph .h 4386 to 4777 400 to 8     Submitted on the opposite strand 393/400
(98 %)
0 diff
(100 %id)
AI564757 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 4389 to 4802 423 to 4       420/423
(99 %)
0 diff
(100 %id)
AI921109 adenocarcinoma, Pancreas .h 4392 to 4780 420 to 27   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 394/395
(99 %)
8 diff
(98.0 %id)
T10371   .h 4398 to 4612 214 to 1     Submitted on the opposite strand 214/214
(100 %)
1 diff
(99.6 %id)
AA131639 uterus .h 4400 to 4615 218 to 1   fully sequenced,   218/218
(100 %)
0 diff
(100 %id)
BM904697 leiomyosarcoma, uterus .h 4426 to 4805 29 to 410   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 382/410
(93 %)
6 diff
(98.6 %id)
W72108 heart .h 4437 to 4616 180 to 1       180/180
(100 %)
2 diff
(98.9 %id)
AI049727   .h 4442 to 4807 375 to 6       370/375
(98 %)
0 diff
(100 %id)
N58100 liver and spleen .h 4470 to 4615 146 to 1       146/149
(97 %)
0 diff
(100 %id)
CB053389 leiomyosarcoma, soft tissue .h 4472 to 4787 10 to 331   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 322/331
(97 %)
8 diff
(97.6 %id)
AA382846 testis .h 4477 to 4609 139 to 7       133/139
(95 %)
0 diff
(100 %id)
N93237 lung .h 4486 to 4801 325 to 1   fully sequenced,   325/325
(100 %)
4 diff
(98.8 %id)
EC516306 Prostate .h 4508 to 4614 110 to 3       108/110
(98 %)
0 diff
(100 %id)
AA923716 pooled .h 4514 to 4802 295 to 4       292/295
(98 %)
0 diff
(100 %id)
CB053388 leiomyosarcoma, soft tissue .h 4517 to 4783 311 to 43   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 269/269
(100 %)
9 diff
(96.7 %id)
BU587306 mixed (pool of 40 RNAs) .h 4519 to 4615 1 to 97   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 97/97
(100 %)
0 diff
(100 %id)
AA709295   .h 4522 to 4782 267 to 1       267/267
(100 %)
2 diff
(99.3 %id)
AI187829   .h 4531 to 4807 285 to 4       282/285
(98 %)
0 diff
(100 %id)
AA830387 germinal center B cell .h 4534 to 4780 280 to 30   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 251/251
(100 %)
2 diff
(99.3 %id)
H82819 liver and spleen .h 4535 to 4712 178 to 1       178/178
(100 %)
1 diff
(99.5 %id)
AA789162   .h 4537 to 4807 275 to 1   tiling clone,   275/275
(100 %)
2 diff
(99.3 %id)
AA862673 pooled germ cell tumors .h 4541 to 4802 265 to 1       265/265
(100 %)
2 diff
(99.3 %id)
FN097106 breast carcinoma .h 4553 to 4615 1 to 62       62/62
(100 %)
3 diff
(95.2 %id)
R63222 placenta .h 4560 to 4783 231 to 1   fully sequenced,   231/231
(100 %)
9 diff
(96.2 %id)
AI828118 anaplastic oligodendroglioma, brain .h 4578 to 4802 229 to 1       229/229
(100 %)
4 diff
(98.3 %id)
AI361169 brain, glioblastoma (pooled) .h 4603 to 4801 203 to 1       203/203
(100 %)
4 diff
(98.1 %id)
AA347917 heart .h 4616 to 4801 186 to 1       186/247
(75 %)
0 diff
(100 %id)
BP231545 muscle .i 1 to 588 1 to 586   tiling clone,   586/586
(100 %)
4 diff
(99.4 %id)
BX376886 Neuroblastoma Cot 50-normalized .i 11 to 1008 2 to 995   tiling clone,   994/995
(99 %)
43 diff
(95.7 %id)
DA494306 brain .i 851 to 1422 2 to 574   tiling clone, capped   573/573
(100 %)
2 diff
(99.7 %id)
DA949071 Spleen .i 853 to 1393 2 to 542   tiling clone, capped   541/541
(100 %)
0 diff
(100 %id)
CR590799 B cells (Ramos cell line) .j 1 to 1205 1 to 1205 exact tiling clone,   1205/1205
(100 %)
0 diff
(100 %id)
AL560247 B cells (Ramos cell line), B cells from Burkitt lymphoma .j 1 to 611 1 to 611   fully sequenced,   611/611
(100 %)
1 diff
(99.9 %id)
AL560246 B cells (Ramos cell line), B cells from Burkitt lymphoma .j 550 to 1205 656 to 1   fully sequenced,   656/656
(100 %)
5 diff
(99.3 %id)
BE834082 ovary .j 686 to 1031 15 to 360       346/362
(95 %)
11 diff
(97.0 %id)
AV748481 Pituitary .j 688 to 1188 489 to 1     Submitted on the opposite strand 489/489
(100 %)
11 diff
(97.8 %id)
BF196856 brain, glioblastoma (pooled) .j 698 to 1240 543 to 1       543/543
(100 %)
9 diff
(98.4 %id)
DB547973 hippocampus .j 770 to 1240 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AI912791 carcinoid, lung .j 784 to 1244 461 to 1   tiling clone,   461/461
(100 %)
2 diff
(99.6 %id)
AI091397 pooled .j 785 to 1240 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
CR742735 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 791 to 1240 464 to 15   AAA   450/450
(100 %)
0 diff
(100 %id)
BG218885   .j 816 to 1240 56 to 481   AAA   426/481
(88 %)
7 diff
(98.6 %id)
AA614740 breast .j 826 to 1245 420 to 1       420/420
(100 %)
3 diff
(99.3 %id)
AI635676 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 829 to 1245 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
AI089664 brain, glioblastoma (pooled) .j 837 to 1245 410 to 2       409/410
(99 %)
0 diff
(100 %id)
AW190074 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 837 to 1240 421 to 17   AAA   405/405
(100 %)
12 diff
(97.1 %id)
AA765256 germinal center B cell .j 884 to 1242 399 to 43   AAA   357/357
(100 %)
4 diff
(98.9 %id)
AI371315 2 pooled tumors (clear cell type), Kidney .j 945 to 1245 305 to 5       301/305
(98 %)
0 diff
(100 %id)
AW665222 pooled .j 962 to 1241 282 to 3       280/282
(99 %)
0 diff
(100 %id)
CA433311 mixed .j 982 to 1240 271 to 13   AAA   259/264
(98 %)
2 diff
(99.3 %id)
BM452092 melanotic melanoma, skin .j 997 to 1240 1 to 244   AAA   244/244
(100 %)
0 diff
(100 %id)
AA620968   .j 1046 to 1241 197 to 3       195/197
(98 %)
0 diff
(100 %id)
AA600037 bone marrow stroma .j 1049 to 1240 218 to 27   AAA   192/192
(100 %)
0 diff
(100 %id)
FN175909 breast carcinoma .j 1155 to 1233 79 to 4     Submitted on the opposite strand 76/79
(96 %)
0 diff
(100 %id)
CB134505 Liver .k 1 to 506 1 to 506   tiling clone,   506/506
(100 %)
2 diff
(99.7 %id)
N28519 melanocyte .k 41 to 455 1 to 419       419/419
(100 %)
4 diff
(99.1 %id)
CD704248 normal nasopharynx .k 46 to 666 19 to 640       622/649
(95 %)
9 diff
(98.7 %id)
NM_172366.2   .k 54 to 1345 1 to 1292 exact RefSeq,   1292/1292
(100 %)
0 diff
(100 %id)
W20154 parathyroid gland, parathyroid tumor .k 56 to 323 1 to 269       269/270
(99 %)
4 diff
(98.6 %id)
DB479287 hippocampus .k 58 to 529 1 to 472       472/472
(100 %)
5 diff
(99.0 %id)
CD709614 normal nasopharynx .k 61 to 414 33 to 386       354/386
(91 %)
7 diff
(98.2 %id)
CB118024 brain .k 63 to 310 1 to 248       248/248
(100 %)
2 diff
(99.2 %id)
AL709090 human skeletal muscle .k 63 to 598 1 to 536       536/536
(100 %)
3 diff
(99.5 %id)
BC102026 PCR rescued clones .k 84 to 1114 1 to 1031 exact tiling clone,   1031/1031
(100 %)
1 diff
(100.0 %id)
AF453435   .k 94 to 1345 1 to 1252 exact tiling clone,   1252/1252
(100 %)
2 diff
(99.9 %id)
BC074986 Pooled tissue, PCR rescued clones .k 104 to 1052 1 to 949 exact available from MGC,   949/949
(100 %)
0 diff
(100 %id)
BQ777185 Pancreas, Purified pancreatic islet .k 174 to 749 1 to 576       576/578
(99 %)
6 diff
(99.0 %id)
BM701024 eye, human retina .k 989 to 1333 3 to 356   fully sequenced,   363/365
(99 %)
44 diff
(88.0 %id)
BM672349 eye, human retina .k 990 to 1313 324 to 1   fully sequenced,   324/324
(100 %)
1 diff
(99.7 %id)
BQ778287 Pancreas, Purified pancreatic islet .k 1139 to 1344 218 to 13   AAA   206/206
(100 %)
2 diff
(99.1 %id)
BC102027 PCR rescued clones .l 1 to 995 1 to 995 M242I T243N     995/995
(100 %)
2 diff
(99.8 %id)
BC102028 PCR rescued clones .l 1 to 995 1 to 995 exact tiling clone,   995/995
(100 %)
0 diff
(100 %id)
CA949941 Pancreas, Purified pancreatic islet .m 1 to 428 1 to 428   tiling clone, fully sequenced,   428/428
(100 %)
4 diff
(99.1 %id)
CA943753 Pancreas, Purified pancreatic islet .m 367 to 941 576 to 1   tiling clone, fully sequenced,   576/576
(100 %)
4 diff
(99.4 %id)
BF594749 Kidney .m 462 to 916 458 to 2   tiling clone,   457/466
(98 %)
6 diff
(98.8 %id)
AI401845 Prostate .m 468 to 794 327 to 1       327/327
(100 %)
1 diff
(99.7 %id)
BF476256 Prostate .n 1 to 639 638 to 1 K2T L3S P4E V6C L7I ... tiling clone,   638/680
(93 %)
11 diff
(98.4 %id)
BF445501 Prostate .n 207 to 639 443 to 11   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 433/443
(97 %)
0 diff
(100 %id)
BF663432 B-cells, primary B-cells from tonsils (cell line) .o 1 to 700 1 to 695 L20W G21D S23V A24P S25R ... tiling clone,   695/697
(99 %)
10 diff
(98.6 %id)
BJ991352 hepatoblastoma .p 1 to 577 10 to 586   tiling clone, to resequence,   577/577
(100 %)
0 diff
(100 %id)
AW835447 leiomios .p 190 to 689 16 to 513       498/513
(97 %)
6 diff
(98.9 %id)
BF357837 leiomios .p 217 to 697 20 to 500   tiling clone,   481/500
(96 %)
7 diff
(98.6 %id)
BJ991353 hepatoblastoma .p 1320 to 1859 540 to 1   tiling clone, to resequence,   540/540
(100 %)
5 diff
(99.1 %id)
BM796594 Ascites, stomach .q-u 123 to 559 1 to 437   tiling clone,   437/437
(100 %)
2 diff
(99.6 %id)
AA814298 germinal center B cell .q-u 138 to 548 411 to 2       410/411
(99 %)
0 diff
(100 %id)
AA765177 germinal center B cell .q-u 144 to 548 406 to 2       405/406
(99 %)
0 diff
(100 %id)
AA809285 germinal center B cell .q-u 189 to 548 357 to 2   tiling clone,   356/357
(99 %)
0 diff
(100 %id)
DA477616   .r 1 to 549 2 to 550 exact tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DB277305 uterus .s 1 to 539 2 to 540 exact tiling clone, capped   539/539
(100 %)
0 diff
(100 %id)
DA356199 subthalamic nucleus .t 1 to 553 2 to 555 A32S A33C R34S C35L P36S ... tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
BQ006846 Chondrosarcoma, Left Pelvis .u 1 to 600 619 to 19 K17X D18G G19W F20I V21C ... tiling clone, AAA   601/601
(100 %)
7 diff
(98.9 %id)
BQ187903 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .va 1 to 394 3 to 396 K24E tiling clone, fully sequenced, AAA   396/396
(100 %)
1 diff
(99.8 %id)
BQ185620 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .va 119 to 394 294 to 19   fully sequenced, AAA   276/276
(100 %)
1 diff
(99.7 %id)
AB044751 testis .vb 1 to 224 1 to 224 exact tiling clone,   224/224
(100 %)
1 diff
(99.6 %id)
BG331738 large cell carcinoma, lung .vc 1 to 590 1 to 592 D19T S20V A22H L23C P25L ... tiling clone,   592/883
(67 %)
12 diff
(98.7 %id)
AK021850 whole embryo, mainly head .vd 1 to 1709 2 to 1709 exact tiling clone, available from FLJ,   1709/1709
(100 %)
5 diff
(99.8 %id)
AU119551 whole embryo, mainly head .vd 1 to 877 2 to 877   capped   876/876
(100 %)
15 diff
(98.3 %id)
BQ301077 bladder_tumor .vd 43 to 607 582 to 16   tiling clone,   567/582
(97 %)
0 diff
(100 %id)
AU145864 whole embryo, mainly head .vd 1135 to 1709 576 to 1 exact     576/584
(98 %)
18 diff
(97.0 %id)
DA385281 thalamus .ve-u 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
4 diff
(99.3 %id)
CV373067 lung_tumor .ve-u 348 to 565 24 to 238       215/238
(90 %)
6 diff
(97.5 %id)
CV373079 lung_tumor .ve-u 348 to 691 23 to 367       345/367
(94 %)
6 diff
(98.4 %id)
CV373720 placenta_normal .ve-u 351 to 699 1 to 346   tiling clone,   346/346
(100 %)
9 diff
(97.4 %id)
CV372872 lung_tumor .ve-u 372 to 731 1 to 359       359/359
(100 %)
6 diff
(98.4 %id)
BF355707 head_neck .ve-u 562 to 750 193 to 5   tiling clone,   189/193
(97 %)
0 diff
(100 %id)
CV318630 head_neck .ve-u 592 to 750 166 to 6     Submitted on the opposite strand 161/167
(96 %)
0 diff
(100 %id)
CV373089 lung_tumor .ve-u 674 to 882 1 to 215       215/246
(87 %)
14 diff
(94.4 %id)
CV372803 lung_tumor .ve-u 675 to 1229 8 to 567   tiling clone,   560/583
(96 %)
11 diff
(98.2 %id)
CV372843 lung_tumor .ve-u 675 to 826 9 to 163       155/163
(95 %)
6 diff
(96.4 %id)
CV373009 lung_tumor .ve-u 675 to 1197 531 to 7 V34D G37V   Submitted on the opposite strand 525/544
(96 %)
0 diff
(100 %id)
CV373960 placenta_normal .ve-u 675 to 1124 16 to 464 exact     449/464
(96 %)
6 diff
(98.8 %id)
CV373998 placenta_normal .ve-u 681 to 1060 1 to 381 R48X D49R K50Q E51G M52D ...     381/381
(100 %)
9 diff
(97.7 %id)
CV373095 lung_tumor .ve-u 702 to 1196 501 to 8 V20F G22A Q25H A31S G37X   Submitted on the opposite strand 494/501
(98 %)
0 diff
(100 %id)
BF912958 uterus_tumor .ve-u 804 to 1003 200 to 1     Submitted on the opposite strand 200/200
(100 %)
0 diff
(100 %id)
CV373088 lung_tumor .ve-u 812 to 1229 422 to 1 V2W T3*   Submitted on the opposite strand 422/422
(100 %)
24 diff
(94.4 %id)
CV359368 colon .ve-u 853 to 1217 29 to 393 exact     365/393
(92 %)
6 diff
(98.5 %id)
CV373751 placenta_normal .ve-u 959 to 1187 238 to 10     Submitted on the opposite strand 229/238
(96 %)
0 diff
(100 %id)
CV372931 lung_tumor .ve-u 992 to 1224 262 to 24     Submitted on the opposite strand 239/270
(88 %)
0 diff
(100 %id)
CV373730 placenta_normal .ve-u 995 to 1205 217 to 6     Submitted on the opposite strand 212/225
(94 %)
0 diff
(100 %id)
BF820221 kidney_tumor .ve-u 1025 to 1356 34 to 365   tiling clone,   332/372
(89 %)
7 diff
(98.2 %id)
BG988111 head_neck .ve-u 1223 to 1550 1 to 328   tiling clone,   328/340
(96 %)
27 diff
(92.1 %id)
AI973205 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vf-u 1 to 386 390 to 5 exact tiling clone,   386/390
(98 %)
0 diff
(100 %id)
AW301171 Kidney .vf-u 326 to 765 441 to 2   tiling clone,   440/441
(99 %)
0 diff
(100 %id)
CX758727 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vg-u 1 to 707 1 to 701 exact tiling clone,   701/874
(80 %)
9 diff
(99.0 %id)
BG977781 colon_ins .vh-u 1 to 244 21 to 265   tiling clone,   245/268
(91 %)
15 diff
(94.5 %id)
BU784886 Pancreas, Purified pancreatic islet .vh-u 13 to 643 631 to 1 exact tiling clone,   631/631
(100 %)
0 diff
(100 %id)
AW377428 colon .vh-u 184 to 484 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
AW377426 colon .vh-u 185 to 484 1 to 301       301/301
(100 %)
4 diff
(98.7 %id)
DB112683 thymus .vi 1 to 583 2 to 584 Q111H tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
DB102994 thymus .vj 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DA372666 thalamus .vk 1 to 417 90 to 506 Q14R S27G T31A Q35R T40A tiling clone, capped   419/509
(82 %)
7 diff
(98.7 %id)
AW977110   Gene FBXO16andZNF395, variant not shown         Submitted on the opposite strand    
AL042596 testis Gene FBXO16andZNF395, variant not shown              
AL042597 testis Gene FBXO16andZNF395, variant not shown              
DB354903 whole embryo, mainly head Gene FBXO16andZNF395, variant not shown         Suspected internal deletion, this clone was ignored    
DA568389 whole embryo, mainly head Gene FBXO16andZNF395, variant not shown       capped Suspected internal deletion, this clone was ignored    
R62825 placenta Gene FBXO16andZNF395, variant not shown              
R62876 placenta Gene FBXO16andZNF395, variant not shown              
AA056610 colon, tumor Gene FBXO16andZNF395, variant not shown              
AA056699 colon, tumor Gene FBXO16andZNF395, variant not shown              
DB360466 mammary gland Gene FBXO16andZNF395, variant not shown         Suspected internal deletion, this clone was ignored    
DA645851 mammary gland Gene FBXO16andZNF395, variant not shown       capped Suspected internal deletion, this clone was ignored    
BP338825 Spleen Gene FBXO16andZNF395, variant not shown         This clone was ignored    
BP374773 umbilical cord Gene FBXO16andZNF395, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve-u, .vf-u, .vg-u, .vh-u, .vi, .vj, .vk Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI